06.10.2010Pathwork Diagnostics Completes $30M Series C Round

Capital to Accelerate Commercialization and Market Share for FDA-cleared Tissue of Origin Test

Press Release

06.10.2010Amsterdam Molecular Therapeutics successfully raised €14.3m through an Equity Issue

Amsterdam Molecular Therapeutics (AMT) Holding N.V. (Euronext: AMT) announces today that it has successfully raised € 14.3 m in gross proceeds through a private placement of new shares with institutional investors

Press Release